======= HINT1 ======= == Gene Information == * **Official Symbol**: HINT1 * **Official Name**: histidine triad nucleotide binding protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3094|3094]] * **UniProt**: [[https://www.uniprot.org/uniprot/P49773|P49773]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HINT1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HINT1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601314|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that hydrolyzes purine nucleotide phosphoramidates substrates, including AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif. This gene is considered a tumor suppressor gene. In addition, mutations in this gene can cause autosomal recessive neuromyotonia and axonal neuropathy. There are several related pseudogenes on chromosome 7. Several transcript variants have been observed. [provided by RefSeq, Dec 2015]. * **UniProt Summary**: Hydrolyzes purine nucleotide phosphoramidates with a single phosphate group, including adenosine 5'monophosphoramidate (AMP-NH2), adenosine 5'monophosphomorpholidate (AMP-morpholidate) and guanosine 5'monophosphomorpholidate (GMP-morpholidate). Hydrolyzes lysyl-AMP (AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) generated by lysine tRNA ligase, as well as Met-AMP, His- AMP and Asp-AMP, lysyl-GMP (GMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) and AMP-N-alanine methyl ester. Can also convert adenosine 5'-O-phosphorothioate and guanosine 5'-O- phosphorothioate to the corresponding nucleoside 5'-O-phosphates with concomitant release of hydrogen sulfide. In addition, functions as scaffolding protein that modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex and by the complex formed with MITF and CTNNB1. Modulates p53/TP53 levels and p53/TP53-mediated apoptosis. Modulates proteasomal degradation of target proteins by the SCF (SKP2-CUL1-F-box protein) E3 ubiquitin- protein ligase complex. {ECO:0000269|PubMed:15703176, ECO:0000269|PubMed:16014379, ECO:0000269|PubMed:16835243, ECO:0000269|PubMed:19112177, ECO:0000269|PubMed:22329685, ECO:0000269|PubMed:22647378, ECO:0000269|PubMed:9323207}. |DcpS C| |HIT| |purine ribonucleotide catabolic process| |ribonucleotide catabolic process| |histone deacetylase complex| |positive regulation of calcium-mediated signaling| |purine nucleotide catabolic process| |intrinsic apoptotic signaling pathway by p53 class mediator| |purine-containing compound catabolic process| |protein kinase C binding| |nucleotide binding| |nucleotide catabolic process| |nucleoside phosphate catabolic process| |hydrolase activity| |regulation of calcium-mediated signaling| |nucleobase-containing small molecule biosynthetic process| |signal transduction by p53 class mediator| |organophosphate catabolic process| |intrinsic apoptotic signaling pathway| |carbohydrate derivative catabolic process| |apoptotic signaling pathway| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |cytoskeleton| |purine-containing compound metabolic process| |nucleobase-containing compound catabolic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organic cyclic compound catabolic process| |nucleobase-containing small molecule metabolic process| |small molecule biosynthetic process| |organophosphate metabolic process| |apoptotic process| |positive regulation of intracellular signal transduction| |carbohydrate derivative metabolic process| |programmed cell death| |organonitrogen compound catabolic process| |cell death| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |positive regulation of signal transduction| |intracellular signal transduction| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp85|UM0129480 7μM R02 exp85]]|-2.08| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.75| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|1.75| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.07| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|3.29| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16085 * **Expression level (log2 read counts)**: 7.15 {{:chemogenomics:nalm6 dist.png?nolink |}}